Replies to post #83748 on Innovation Pharmaceuticals Inc (IPIX)

[cabel]

Thanks BK for a very insightful post and for enligthening us all!!

[alwaysdreaming]

"This was huge and new news today that many treated as fluff."

No offense, but the market reacted differently. Why? Maybe because Leo used the word, "Momentous" and with no, to date, Momentous news, we tanked from the "momentous news" that we received today...? Perhaps maybe Leo/Aspire is still selling into Momentous news...?

Maybe Leo, stating in November "Momentous", was referring to the fact that there would be a "Moment"ous when our portfolio's would jump big time, and therefore we should all have sold a chunk of shares too give us that holiday bonus we were all believing we would get, but instead would of gotten, if we were all "traders".

Year aint over yet, but if this is all he's got for the holiday season he should of saved that Q announcement for this week instead of 2 weeks ago.

Always trust Leo...

[Chemdeps]

Great read on the PR BK...helps to have someone interpret what the words actually mean. I still think there are some significant catalysts coming up in the very short term. For example, I find it interesting that the safety board met on K but nothing has been said about the next cohort other than the conference in early January. Typically I thought we heard about the next cohort very soon after the safety board meets but perhaps I am wrong....this is what the November 24 PR said "The Company anticipates that the Kevetrin trial is nearing its conclusion with the start of the tenth cohort next month".

If anything, I think this is good news like Kelt said...if it was bad news they would have to release the information. I recognize it could simply be a delay, but it is a little odd. Here's hoping for a surprise!

[JUST 10-11-12]

you give me hope BIG GUY! HAVE A WONDERFUL HOLIDAY, and
here is to a VERY PROSPEROUS CTIX NEXT YEAR AND AFTER.

Keith, Gail, Matthew

[F1ash]

Fortunately, thanks to the Phase 2a we already have a reasonable idea of what to expect from bottom line data.

edit: I'm sure you have already seen these but I thought some of the traders might need to see what the product is all about.







https://images.search.yahoo.com/images/view;_ylt=A0LEVv3XvJhUaTUAs1gPxQt.;_ylu=X3oDMTBsa3ZzMnBvBHNlYwNzYwRjb2xvA2JmMQR2dGlkAw--?p=phase+2+polymedix+brilacidin&back=https%3A%2F%2Fsearch.yahoo.com%2Fyhs%2Fsearch%3Fp%3Dphase%2B2%2Bpolymedix%2Bbrilacidin%26ei%3DUTF-8%26hsimp%3Dyhs-001%26hspart%3Dmozilla&w=3508&h=2480&imgurl=cellceutix.com%2Fwp-content%2Fuploads%2F2012%2F07%2FChart-4.jpg&size=2095KB&name=Chart-4.jpg&rcurl=http%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D93731604&rurl=http%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D93731604&type=&no=1&tt=118&oid=80df43180a7479e54dd8c8c09ad01af7&tit=http%3A%2F%2Fcellceutix.com%2Fwp-content%2Fuploads%2F2012%2F07%2FChart-4.jpg&sigr=126j6je8o&sigi=11lb9pt68&sign=10bledd26&sigt=1034t694l&sigb=13855q8s5&fr=yhs-mozilla-001&hspart=mozilla&hsimp=yhs-001#

[F1ash]

This is probably the importance behind the MRSA data:

[edge]

Leo turning up the Cellceutix afterburners yet again. It just never ends, we better come with another name besides Momentus, and as they say in Seattle Seahawks land, holy catfish..............touchdown! BK, Drano, 58nout, Citrati and Warrenthomas to you all my posts of the week. The delay overshadowed everything else, batten down the hatches buy stops here at 4.50.

[brucethepotter]

Hey BK, I looked up pharmacokinetics and it looks like the additional data requested is about how the drug is metabolized etc. This seems important to me. Is it important? It doesn't seem like efficacy or other questions.
http://i.word.com/idictionary/pharmacokinetics

[TheHound]

Here's what we were expecting in your own words:

-Cohort 10 news for Kevetrin
-Phase 3 news for Brilacidin ABSSSI--FDA meeting outcomes including fast-track definitions
-Phase 2 start and protocol Brilacidin OM--FDA meeting outcomes including fast-track definitions
-Phase 2 or 2/3 news Prurisol--
-All 4 of the above.

Here's what we got:

-Positive Results of Brilacidin in Microbiological Intent-to-Treat Population in Phase 2b ABSSSI Trial
-Additional Pharmacokinetic Information to Be Submitted.
-IRB Approval to Start Oral Mucositis Trial
-Grant Awarded for HDP Mimics
-Biotech Showcase on Tap

Definitely not fluff. Definitely not what we were expecting.

You're not the least bit disappointed?